Angioplasty of the septal perforators: acute outcome and long-term clinical efficacy.

Critical stenosis of a large septal perforator artery can cause significant myocardial ischemia. Since septal perforators are generally not accessible for bypass grafting, balloon angioplasty offers an excellent alternative for revascularization of these vessels. The short-term outcome and long-term clinical follow-up angioplasty of the septal perforator was evaluated retrospectively in 21 patients. Fourteen of the 21 (66%) had previous myocardial infarction, 9 of 21 (43%) had previous coronary bypass surgery, 10 of 21 (48%) had previous percutaneous transluminal coronary angioplasty (PTCA), and 6 of 21 (28%) had congestive heart failure. Additional PTCA of one or more vessels was undertaken in all patients. Primary success of PTCA of the septal perforator was achieved in 20 of 21 (95%) patients. The mean stenosis was improved from 89.8 +/- 10% to 18.4 +/- 11.7%. No acute closure, emergency coronary bypass, or myocardial infarction was observed or needed during hospital stay. At long-term follow-up (18 +/- 9 months), event-free survival was 95%. No cardiac death occurred. In 86% of cases, there was significant improvement in anginal class at 2 years. Five of the six patients with congestive heart failure showed marked improvement in functional class at 2 years. In conclusion, balloon angioplasty of the large septal perforator artery is technically feasible, with a high success rate, and does not increase the rate of acute complications of the procedure. Along with PTCA of other arteries, it provides long-term relief of angina in a majority of symptomatic patients with complex multivessel disease.(ABSTRACT TRUNCATED AT 250 WORDS)